Global Biobanking Market Size study & Forecast, by Sample Storage (Blood, Cells & Tissue, and Others) by Application (Regenerative Medicines, Life Sciences, and Others) by Settings (Academic Medical Institutes, and Pharmaceutical & Biotechnology Companies

The Global Biobanking Market, currently valued at approximately USD 155.91 billion in 2024, is on track to expand at an exceptional CAGR of 35.59% during the forecast period of 2025–2035. Biobanking, which entails the systematic collection, storage, and management of biological specimens such as blood, cells, and tissues, has evolved into a critical infrastructure for advancing medical research, diagnostics, and therapeutic innovation. These repositories serve as the backbone of precision medicine, enabling researchers to decode complex disease pathways, validate biomarkers, and accelerate the development of targeted therapies. The market’s rapid growth is propelled by the surge in chronic disease prevalence, exponential advancements in genomics, and the proliferation of regenerative medicine applications that demand high-quality biospecimens for both discovery and clinical validation. Moreover, as data integration and bioinformatics technologies mature, the synergy between biological sample repositories and advanced analytics is unlocking unprecedented insights into human health, thus amplifying the relevance and value proposition of biobanks across the globe.

A pronounced shift towards personalized and regenerative healthcare has further elevated the strategic importance of biobanking. These facilities not only safeguard critical biospecimens for future use but also actively contribute to ongoing research by facilitating access to ethically sourced, well-characterized samples. The emergence of large-scale population-based biobanks, coupled with public–private collaborations, has widened the scope of translational research and drug development pipelines. According to recent industry analyses, the growing adoption of stem cell therapies, the rise of cell and gene therapy trials, and the integration of artificial intelligence in biospecimen analysis are set to redefine operational models and enhance efficiency in sample utilization. However, the market’s expansion faces hurdles such as stringent regulatory frameworks governing consent and data privacy, high infrastructure costs, and the technical complexities associated with long-term sample preservation. Despite these challenges, ongoing innovations in cryopreservation, automated sample handling, and cloud-based data management platforms continue to push the boundaries of what biobanks can achieve.

Regionally, North America is projected to maintain a commanding lead in the global biobanking market during the forecast horizon, supported by a robust healthcare ecosystem, extensive R&D funding, and the presence of major pharmaceutical and biotechnology firms actively engaged in biomarker discovery and personalized medicine initiatives. The region’s strong regulatory oversight and commitment to ethical governance also reinforce public trust in biobanking activities. Europe, with its established network of academic research centers and collaborative biobanking projects, follows closely, leveraging cross-border data sharing frameworks and investments in genomic infrastructure. Meanwhile, the Asia Pacific region is poised for the fastest growth, driven by surging healthcare expenditure, burgeoning biotechnology sectors in countries like China, India, and Japan, and government-led initiatives to develop national biobanking programs. These efforts, combined with the region’s large and genetically diverse populations, are attracting global partnerships aimed at enhancing sample diversity and research applicability.

Major market players included in this report are:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Lonza Group AG
• BioCision, LLC
• Hamilton Company
• Qiagen N.V.
• Tecan Group Ltd.
• Avantor, Inc.
• Brooks Life Sciences
• Chart Industries, Inc.
• Biovault Family
• STEMCELL Technologies Inc.
• Greiner Bio-One International GmbH
• Biostorage Technologies, Inc.
• Becton, Dickinson and Company

Global Biobanking Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Sample Storage:
• Blood
• Cells & Tissue
• Others

By Application:
• Regenerative Medicines
• Life Sciences
• Others

By Settings:
• Academic Medical Institutes
• Pharmaceutical & Biotechnology Companies

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more